An orally bioavailable Hsp90 inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

XL888

Item No. 16309

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
N1-[(3-endo)-8-[5-(cyclopropylcarbonyl)-2-pyridinyl]-8-azabicyclo[3.2.1]oct-3-yl]-2-methyl-5-[[(1R)-1-methylpropyl]amino]-1,4-benzenedicarboxamide
CAS Number
1149705-71-4
Molecular Formula
C29H37N5O3
Formula Weight
503.6
Purity
≥98%
Formulation
A crystalline solid
Solubility(Learn about Variance in Solubility)
DMF: 30 mg/mlDMSO: 30 mg/mlDMSO:PBS (pH 7.2)(1:5): 0.1 mg/ml
λmax
220, 265, 325 nm
SMILES
CC1=CC(C(N)=O)=C(N[C@H](C)CC)C=C1C(N[C@@H]2C[C@@H](N3C4=NC=C(C(C5CC5)=O)C=C4)CC[C@@H]3C2)=O
InChi Code
InChI=1S/C29H37N5O3/c1-4-17(3)32-25-14-23(16(2)11-24(25)28(30)36)29(37)33-20-12-21-8-9-22(13-20)34(21)26-10-7-19(15-31-26)27(35)18-5-6-18/h7,10-11,14-15,17-18,20-22,32H,4-6,8-9,12-13H2,1-3H3,(H2,30,36)(H,33,37)/t17-,20-,21+,22-/m1/s1
InChi Key
LHGWWAFKVCIILM-HLRQEUIKSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $54

    Add

    5 mg

    $238

    Add

    10 mg

    $367

    Add

    25 mg

    $653

    Add
    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    XL888 is an ATP-competitive inhibitor of Hsp90.1 Through this action, specific client proteins are degraded, resulting in cell cycle arrest or apoptosis.2,3,4 XL888 is orally bioavailable and shows efficacy in tumor regression in gastric carcinoma and melanoma xenografts in mice.1,3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Bussenius, J., Blazey, C.M., Aay, N., et al. Discovery of XL888: A novel tropane-derived small molecule inhibitor of HSP90. Bioorg. Med. Chem. Lett. 22(17), 5396-5404 (2012).

    2. Lyman, S.K., Crawley, S.C., Gong, R., et al. High-content, high-throughput analysis of cell cycle perturbations induced by the HSP90 inhibitor XL888. PLoS One 6(3), 1-14 (2011).

    3. Haarberg, H.E., Paraiso, K.H.T., Wood, E., et al. Inhibition of Wee1, AKT, and CDK4 underlies the efficacy of the HSP90 inhibitor XL888 in an in vivo model of NRAS-mutant melanoma. Mol. Cancer Ther. 12(6), 901-912 (2013).

    4. Paraiso, K.H.T., Haarberg, H.E., Wood, E., et al. The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanisms. Clin. Cancer Res. 18(9), 2502-2514 (2012).